Depression Prevalence in Neuropathic Pain and Its Impact on the Quality of Life

Table 1

NP characteristics of the study population.

NP4 score	6.49 ± 1.54
Pain etiology	Diabetic neuropathy	6
	Postherpetic pain	11
	Pain of rheumatic origin	32
	Others	12
	7.57 ± 1.73
Pain intensity according to EVA	Moderate intensity	18 (29.5)
	Severe intensity	43 (70.5)
Pain history	2 years (min: 1 month; max: 25 years)
Pain evolution	≥6 months	49 (80.3)
	<6 months	12 (12.7)
Treatment	Without treatment	20 (32.8)
	With treatment	40 (67.2)
Treatment duration	1.29 years (min: 0; max: 15 years)
Number of treatments	Monotherapy	13 (32.5)
	Polytherapy (≥2 medicines)	27 (67.5)
Treatment nature	Morphine	3
	Tramadol	16
	Paracetamol	25
	NSAIDs	5
	Tricyclic antidepressants	17
	New antiepileptics	13
	Classical antiepileptics	3

Mean ± standard deviation; lumbosciatic, cervicobrachial neuralgia, carpal tunnel syndrome, and polyradiculopathy; stroke, postsurgery, oncological, neuralgia of 6. NP4: Neuropathic Pain 4 questionnaire; VAS: Visual Analogic Scale; min: minimal value; max: maximal value, number (%); NSAI: nonsteroidal anti-inflammatory.